Xiamen,China – On first and second day of November of this year, the final meeting for assessment of Hepatitis E vaccine was held smoothly at INNOVAX. The outcome from the assessment was optimistically positive.
As the world’s only Hepatitis E vaccine manufacturer, Innovax is committed to be an international supplier of high quality vaccines for the benefit of global public health and is keen to increase global access to this vaccine for people in urgent need. This assessment was a milestone paving the technical pathway towards WHO PQ (Pre-Qualification, the WHO regulatory requirement).